Among such mechanisms, histone methyltransferases—key enzymes responsible for histone methylation—have emerged as critical factors in cancer progression and metastasis, not only in CRC but across multiple cancer types, making them important targets for therapeutic development [22, , -25]. This evidence concerns the gene PRDM9 and colorectal carcinoma.